Genesis Clinical Research Private Limited - Company Profile

It is a chemicals private limited company based in New Delhi, Delhi, India, established in 2007.

2007 New Delhi, Delhi, India Struck Off

Last Updated: July 21, 2025

About Genesis Clinical Research Private Limited

Genesis Clinical Research Private Limited, a struck off private limited company, was established on 22 November 2007 in New Delhi, Delhi, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24239DL2007PTC170665. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M.

Its leadership includes Sudeep Singh Narula (Director), Preet Mohan Singh Randhawa (Director), Jasjit Singh Walia (Director). Past directors included Santokh Singh Narula. It is based at E-347, Greater Kailash-I, New Delhi, Delhi, 110048.

Company Details

CIN/LLPIN
U24239DL2007PTC170665
Registration Number
170665
Incorporation Date
22 November 2007
Authorized Capital
₹1.00 M
ROC Code
Roc Delhi
Listing Status
Unlisted
Company Status
Struck Off

Key Metrics

Authorised Capital ₹ 1.00 M as on 21-07-2025
Company Age 18 Year, 3 Months

Comprehensive Company Insights

Explore comprehensive insights into Genesis Clinical Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Genesis Clinical Research Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Sudeep Singh Narula	Director	22 Nov 2007	Current
Preet Mohan Singh Randhawa	Director	11 Feb 2008	Current
Jasjit Singh Walia	Director	15 Dec 2007	Current
Prince Pal Singh Bachitr Tuli	Director	15 Dec 2007	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	11 Feb 2008	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Genesis Clinical Research.

Enhance accessibility to Genesis Clinical Research's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Genesis Clinical Research?

Unlock access to Genesis Clinical Research's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Genesis Clinical Research?

Unlock and access historical data on people associated with Genesis Clinical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Genesis Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Genesis Clinical Research's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Genesis Clinical Research

Recent Activity within the Organization

Director Appointment

The activity Preet Mohan Singh Randhawa was appointed as a Director was appointed as a Director on 11 Feb 2008 & has been associated with this company since 18 years 1 month . was completed.
11 Feb 2008
Director Appointment

Jasjit Singh Walia was appointed as a Director was appointed as a Director on 15 Dec 2007 & has been associated with this company since 18 years 2 months . was recorded as a recent event.
15 Dec 2007
Director Appointment

The activity Prince Pal Singh Bachitr Tuli was appointed as a Director was appointed as a Director on 15 Dec 2007 & has been associated with this company since 18 years 2 months . was completed.
15 Dec 2007
Director Appointment

The activity Sudeep Singh Narula was appointed as a Director was appointed as a Director on 22 Nov 2007 & has been associated with this company since 18 years 3 months . was completed.
22 Nov 2007
Company Incorporation

Progress on Genesis Clinical Research Private Limited was registered on 22 Nov 2007 with Roc Delhi & aged 18 years 3 months as per MCA records. was documented.
22 Nov 2007

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions

What is the CIN of Genesis Clinical Research Private Limited?

The CIN of Genesis Clinical Research Private Limited is U24239DL2007PTC170665.

Where is Genesis Clinical Research Private Limited headquartered?

Genesis Clinical Research Private Limited is headquartered at E-347, Greater Kailash-I, New Delhi, Delhi, 110048.

When was Genesis Clinical Research Private Limited incorporated?

Genesis Clinical Research Private Limited was incorporated on 22 November 2007.

Who are the current directors of Genesis Clinical Research Private Limited?

The current directors of Genesis Clinical Research Private Limited are

What is the primary industry of Genesis Clinical Research Private Limited?

The primary industry of Genesis Clinical Research Private Limited is Chemicals.

Is Genesis Clinical Research Private Limited a listed company?

Genesis Clinical Research Private Limited is unlisted.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available